Rosavins are a standardized extract from *Rhodiola rosea* root, set to a minimum of 3% rosavins and 0.8% to 1% salidroside. Manufacturers make this extract to keep active compound levels steady from batch to batch. Clinical researchers often pick this form because of that consistency. Most people take it in the morning or early afternoon, typically with food.
Mixed research clouds the picture here. Many trials rely on other standardizations, like a 2% salidroside extract. Tighter standardization does not guarantee stronger effects.
Rhodiola can interact with serotonergic drugs such as SSRIs and MAOIs, possibly raising the odds of serotonin syndrome. Taking it late in the day might cause over-alertness or trouble sleeping. Pregnant and breastfeeding women should skip it because safety data is missing.